Press Releases
- 10-year extension for FIA WEC agreed between FIA and ACO until 2037
- Significantly enhanced FIA branding across the championship
- Common ambition to expand partnership and drive commercial growth
- Stronger and consistent regulatory oversight; all regulations will be approved by the FIA Endurance Commission and FIA World Motor Sport Council
- ‘Golden Age’ for FIA WEC as audience grows more than 8% in 12 months
- Deal marks the fourth long-term agreement for FIA... (continue reading...)
BeiJing, China - September 30, 2026 - On October 2, the“Hearing Each Other” 2026 World Rivers Gala, produced by the China Media Group's Global Chinese Program Center, will be broadcast at 17:30 on CCTV-4 and other new media platforms of China Media Group.
The Gala resounded at the "Eternal Life" sculpture square in Wanzhou District, Chongqing. Musicians and guests from nearly 20 countries and regions, including the United States, France, Germany, Egypt, Kazakhstan, and... (continue reading...)
KALMAR CORPORATION, TRADE PRESS RELEASE, 30 SEPTEMBER 2026 AT 9:15 (EEST)
Kalmar wins preventive and corrective maintenance contract for STS and ASC cranes at TTI Algeciras
Kalmar has signed a Kalmar Care service agreement with Total Terminal International Algeciras S.A. (TTI Algeciras) in Spain to deliver mechanical preventive and corrective maintenance service for their 8 Ship-to-Shore (STS) and 32 Automated Stacking Cranes (ASC). The order was booked in Kalmar’s Q3... (continue reading...)
STOCKHOLM, Sept. 30, 2026 /PRNewswire/ -- As per 30 September 2026, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 357,636,514 shares. All shares are common shares. The total number of votes is 357,636,514. The increase in the number of shares and votes results from the issue of 223,677 class C shares. The class C shares were issued for the purpose of ensuring fulfilment of commitments under the long-term incentive... (continue reading...)
Tonner Drones publishes its semi-annual results 2026
Paris, September 30, 2026, 8:00 a.m. – Tonner Drones is announcing its preliminary results for the first half of 2026 today.
Revenue declined further to €27k, due to changes in the business model. Tonner Drones continues to adhere to a strict cost-control policy, which enabled it to further reduce operating costs to €233k. Partly as a result, the company’s financial results improved by €300k, and net profit landed... (continue reading...)
More Press Releases
View Older Stories-
Orion Corporation completed share acquisitions
-
ICG Silver & Gold Intersects 24.3 Meters of 10.14 g/t Gold, Including 4.6 Meters of 51.84 g/t Gold and 10.2 g/t Silver, at the Tuscarora District, Nevada
-
Klarvant Expands Namespace Command With Automation and Machine-to-Machine Access for AI Systems
-
Orosur Mining Inc: Total Voting Rights
-
Alpha Growth Management Opens Rep Office in Japan
-
Q1 Trading Statement 2026/27: Bang & Olufsen generated revenue growth of 2.2% in local currencies
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - September 30
-
Juicebox Opens London Office as UK and EMEA Companies Rethink How They Hire
-
Alpha Longevity Management Rebrands as Alpha Growth Management (Bermuda) Ltd; Establishes Representative Office in Japan
-
Sun Mountain Partners, a Shareholder of Ashtead Technology, Urges the Board to Reject Ember’s 615p Proposal
-
The Board of Directors of IQM Quantum Computers Plc has resolved to establish new share-based long-term incentive plans for the employees of the group
-
Haffner Energy will market the hydrogen produced at Marolles via an HRS station
-
AnaCardio raises €62.5 million Series B financing to advance transformational novel therapy in heart failure towards Phase 3 readiness
-
NBPE Announces Transaction in Own Shares
-
Commencement of Share Buyback Programme
-
Transaction in Own Shares
-
Orion Corporation: Acquisition of own shares during week 40, 2026
-
Total Voting Rights
-
Guardian Metal Resources PLC Announces Total Voting Rights
-
Breaking the Safety Barrier: Insilico Medicine Nominates ISM1354, the Next-Generation Small Molecule GIPR Antagonist
-
Tetragon Financial Group Limited August 2026 Monthly Factsheet
-
Smart, Secure and Scalable: Flatworld Mortgage Reimagines Mortgage Operations
-
Apeing Raises the Stakes: 281,538,380 Tokens Burned as Apeing Enters the Next Crypto to Explode Conversation With Bitcoin and BNB in Focus
-
AbbVie Highlights Positive Results from the Phase 2 APEX Part B Study of Zumilokibart in Moderate to Severe Atopic Dermatitis, as a Late Breaker at EADV 2026
-
TomTom brings location intelligence to Microsoft Fabric
-
CIO Launches SmartCoby Ultra Slim SS5K on Kickstarter, Building on Ultra Slim 3K's Breakout Crowdfunding Success
-
Thomas Roofing and Repair Named Among Top Roofing Contractors in Orlando, FL by ThreeBestRated
-
Pyxis Oncology Announces Pricing of Up to $282.6 Million Public Offering
-
How Constant Finance Is Rethinking the Fixed-Rate Lending Experience
-
Kodiact Introduces the First Intelligent Simulation Platform for Direct Materials
-
Fall Wardrobe Quality Upgrade: COOFANDY Unveils Early Fall Menswear Preview
-
Pro-Grade AI Diagnosis, Without the Pro-Grade Price: THINKSCAN 689BT PRO Brings 610 Racing’s Know-How to the DIYer
-
VDURA Data Platform V12 Now Generally Available, the Hyperscaler Storage Playbook to AI Factories and Neoclouds on Supermicro
-
59/2026・Trifork Group AG initiates cancellation of 2.5% of its share capital
-
Egle Therapeutics Announces Positive Phase 1 Data for EGL-003, Showing Favorable Safety and Selective Treg Expansion in Healthy Volunteer Study
-
Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026
-
Genentech’s Fenebrutinib Is the First BTK Inhibitor to Receive U.S. FDA Filing Acceptance in Both Relapsing and Primary Progressive Multiple Sclerosis
-
Zasocitinib Delivered Superior Efficacy Versus Deucravacitinib in New Phase 3 Head-to-Head Results, Reinforcing Potential to Deliver Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill
-
EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis
-
Roche launches newborn screening test for three severe genetic conditions
-
AbbVie Showcases Leadership in Dermatology Research With New Clinical and Real-World Evidence Across Immune-Mediated Skin Diseases at 2026 EADV Congress
-
Greta Garbo is back - starring in SKF's initiative to overcome friction
-
Navigator Medicines Presents New Data at EADV 2026 as Bispecific Antibody Program Advances at Speed in Hidradenitis Suppurativa
-
Roche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis
-
Start of Day Message
-
Santhera Pharmaceuticals Half Year Results for the six months ending 30 June 2026
-
SkiStar AB Year-End Report September 2025-August 2026
-
58/2026・Trifork Group AG convenes Extraordinary General Meeting to approve special dividend and increase capital band
-
Announcement of change in the total number of votes in AB SKF
-
Sophia Space and Redwire Team Up to Advance Orbital Data Center Infrastructure
